Annual Total Liabilities
$226.83 M
+$187.33 M+474.23%
December 31, 2023
Summary
- As of February 12, 2025, TRDA annual total liabilities is $226.83 million, with the most recent change of +$187.33 million (+474.23%) on December 31, 2023.
- During the last 3 years, TRDA annual total liabilities has risen by +$141.81 million (+166.81%).
- TRDA annual total liabilities is now at all-time high.
Performance
TRDA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$132.14 M
-$19.89 M-13.09%
September 30, 2024
Summary
- As of February 12, 2025, TRDA quarterly total liabilities is $132.14 million, with the most recent change of -$19.89 million (-13.09%) on September 30, 2024.
- Over the past year, TRDA quarterly total liabilities has dropped by -$106.23 million (-44.56%).
- TRDA quarterly total liabilities is now -53.97% below its all-time high of $287.07 million, reached on June 30, 2023.
Performance
TRDA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TRDA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +474.2% | -44.6% |
| 3 y3 years | +166.8% | +234.5% |
| 5 y5 years | +572.0% | +234.5% |
TRDA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3088.1% | -54.0% | +1757.3% |
| 5 y | 5-year | at high | +3088.1% | -54.0% | +1757.3% |
| alltime | all time | at high | +3088.1% | -54.0% | +1757.3% |
Entrada Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $132.14 M(-13.1%) |
| Jun 2024 | - | $152.04 M(-37.0%) |
| Mar 2024 | - | $241.48 M(+6.5%) |
| Dec 2023 | $226.83 M(+474.2%) | $226.83 M(-4.8%) |
| Sep 2023 | - | $238.37 M(-17.0%) |
| Jun 2023 | - | $287.07 M(+16.7%) |
| Mar 2023 | - | $245.96 M(+522.6%) |
| Dec 2022 | $39.50 M | $39.50 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $41.24 M(+3.4%) |
| Jun 2022 | - | $39.88 M(+1.4%) |
| Mar 2022 | - | $39.31 M(+452.5%) |
| Dec 2021 | $7.12 M(-91.6%) | $7.12 M(-96.5%) |
| Sep 2021 | - | $204.99 M(+1.2%) |
| Jun 2021 | - | $202.53 M(+138.2%) |
| Dec 2020 | $85.02 M(+151.9%) | $85.02 M |
| Dec 2019 | $33.76 M | - |
FAQ
- What is Entrada Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics annual total liabilities year-on-year change?
- What is Entrada Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly total liabilities year-on-year change?
What is Entrada Therapeutics annual total liabilities?
The current annual total liabilities of TRDA is $226.83 M
What is the all time high annual total liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high annual total liabilities is $226.83 M
What is Entrada Therapeutics annual total liabilities year-on-year change?
Over the past year, TRDA annual total liabilities has changed by +$187.33 M (+474.23%)
What is Entrada Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TRDA is $132.14 M
What is the all time high quarterly total liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly total liabilities is $287.07 M
What is Entrada Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TRDA quarterly total liabilities has changed by -$106.23 M (-44.56%)